Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell Target – Investing.com

Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell TargetInvesting.comStem Cell Therapeutics Corp., (SSS) is advancing SIRP Fc, an anti-CD47 fusion protein targeting cancer stem cells (CSCs) and bulk tumour cells (BTCs) in acute myeloid leukaemia (AML). SCT raised C$33m in capital in late 2013 to fund SIRP Fc read more
http://blog.zandcell.com/stem-cell-therapeutics-moving-ahead-with-cancer-stem-cell-target-investing-com/?utm_source=rss&utm_medium=rss&utm_campaign=stem-cell-therapeutics-moving-ahead-with-cancer-stem-cell-target-investing-com